All lobbying filings

Capitol Counsel LLC

Capitol Counsel LLC filed a Q3 report for Glaxosmithkline LLC on October 18, 2026, reporting $50,000 in lobbying income.

Lobbying for Glaxosmithkline LLC · Pharmaceuticals.

As filed: CAPITOL COUNSEL LLC for GLAXOSMITHKLINE LLC.

All filings by Capitol Counsel LLC · Everything Glaxosmithkline LLC has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 18, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Advocacy on healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. Reauthorization of the Prescription Drug User Fee Act (FDUFA).

Medicare/Medicaid

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.